Self-interaction of soluble and surface-bound beta2-glycoprotein I and its enhancement by lupus anticoagulants.
Antiphospholipid antibodies found in antiphospholipid syndrome are autoantibodies to phospholipid-binding proteins, such as beta2-glycoprotein I (beta2GPI). We have previously reported that among these antibodies, the so-called lupus anticoagulants (LAs) augment beta2GPI binding to the phospholipid membrane surface, which is associated with the pathological action of LAs. However, the molecular mechanisms underlying this augmentation are uncertain. Here we show that beta2GPI, which is monomeric in solution, self-interacts at the interface of soluble and surface-bound molecules. In addition, this self-interaction is enhanced by LA-positive, but not LA-negative, anti-beta2GPI monoclonal antibodies. This study suggests that beta2GPI self-interaction upon surface binding could be involved in the LA-induced potentiation of beta2GPI binding to the phospholipid surface.
Hayashi
Akira
A
Division of Pathological Biochemistry, Department of Life Sciences, Tottori University, Faculty of Medicine, Yonago 683-8503, Japan.
Hayashi
Ayumi
A
Matsuura
Eiji
E
Suzuki
Koji
K
Koike
Takao
T
Hashimoto
Eikichi
E
Takeya
Hiroyuki
H
D000911:Antibodies, Monoclonal / Q000276:immunology; D000937:Antigen-Antibody Reactions; D002462:Cell Membrane / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000737:chemistry / Q000276:immunology*; D009994:Osmolar Concentration; D010743:Phospholipids / Q000276:immunology*; D012995:Solubility; D020349:Surface Plasmon Resonance; D053482:beta 2-Glycoprotein I / Q000737:chemistry / Q000276:immunology*
D000911:Antibodies, Monoclonal; D016682:Lupus Coagulation Inhibitor; D010743:Phospholipids; D053482:beta 2-Glycoprotein I